- Home
- SEER vs AXR Comparison
SEER vs AXR Comparison
Compare SEER & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- AXR
- Stock Information
- Founded
- SEER 2017
- AXR 1961
- Country
- SEER United States
- AXR United States
- Employees
- SEER 134
- AXR N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- AXR Homebuilding
- Sector
- SEER Health Care
- AXR Real Estate
- Exchange
- SEER Nasdaq
- AXR Nasdaq
- Market Cap
- SEER 121.8M
- AXR 110.0M
- IPO Year
- SEER 2020
- AXR N/A
- Fundamental
- Price
- SEER $1.84
- AXR $21.79
- Analyst Decision
- SEER Hold
- AXR
- Analyst Count
- SEER 1
- AXR 0
- Target Price
- SEER $3.00
- AXR N/A
- AVG Volume (30 Days)
- SEER 174.6K
- AXR 13.1K
- Earning Date
- SEER 05-13-2025
- AXR 03-07-2025
- Dividend Yield
- SEER N/A
- AXR N/A
- EPS Growth
- SEER N/A
- AXR 472.07
- EPS
- SEER N/A
- AXR 2.41
- Revenue
- SEER $14,170,000.00
- AXR $58,052,000.00
- Revenue This Year
- SEER $23.54
- AXR N/A
- Revenue Next Year
- SEER $42.98
- AXR N/A
- P/E Ratio
- SEER N/A
- AXR $9.09
- Revenue Growth
- SEER N/A
- AXR 30.35
- 52 Week Low
- SEER $1.56
- AXR $15.88
- 52 Week High
- SEER $2.63
- AXR $39.67
- Technical
- Relative Strength Index (RSI)
- SEER 41.77
- AXR 47.78
- Support Level
- SEER $1.88
- AXR $21.15
- Resistance Level
- SEER $1.97
- AXR $22.97
- Average True Range (ATR)
- SEER 0.10
- AXR 1.06
- MACD
- SEER -0.02
- AXR -0.09
- Stochastic Oscillator
- SEER 0.00
- AXR 23.78
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.